Aura Biosciences, Inc.

8.76 USD
+0.01 (+0.11%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Aura Biosciences, Inc. stock is up 13.91% since 30 days ago. The next earnings date is Mar 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November. 100% of analysts rate it a buy.

About Aura Biosciences, Inc.

Aura Biosciences, Inc. develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.